Curevo, Inc. announced that will issue 9,907,103 series A-1 preferred stock at a price of $2.62438 per share for gross proceeds of $26,000,003 on November 9, 2022. The shares will be convertible into common shares at a fixed conversion price of $2.62438 per share. The shares of preferred stock will carry a non-cumulative dividend of 8% per annum.

The company will issue securities pursuant to exemption provided under Regulation D. The transaction will include participation from Janus Henderson Group plc, RA Capital Management, L.P., Adjuvant Capital, LP and Green Cross Corporation.